Top Medical News
Roshini Claire Anthony, 10 hours ago

Metformin treatment in patients with type 2 diabetes (T2D) may have an added benefit – reduction in colorectal cancer (CRC) or colorectal adenoma incidence, a recent meta-analysis suggested.

Children with gastro-oesophageal reflux disease (GERD) are at heightened risk of developing asthma, and those with asthma are prone to develop GERD, according to a study, which suggests that the two conditions have a bidirectional relationship.
4 days ago
The serum profile of antibodies and proteins may help identify patients at risk of developing Crohn’s disease within 5 years, a new study reports.
4 days ago
A short meal-to-bedtime may cause problems during pregnancy, contributing to an increased risk of gastroesophageal reflux disease (GERD) and reflux-related insomnia, a study has found.
5 days ago
The presence of any atopic disease increases the risk of developing inflammatory bowel disease, which rises progressively as the number of atopic disease increases, a study has found.
6 days ago
Routine prophylactic clipping after polypectomy may not decrease postoperative bleeding, a new meta-analysis has found. However, it may reduce bleeding after the excision of large proximal lesions.
06 Aug 2020
Keeping a healthy lifestyle and having regular colonoscopy screenings are effective measures to reduce the risk of developing colorectal cancer (CRC), a new study has shown.
Special Reports
10 Mar 2020
RB Health is committed to support healthcare quality improvement through CME activities that help physicians stay updated with the latest developments in medicine. At the RB symposium held in Kuala Lumpur, two distinguished speakers gave their insights into the management of acid reflux and sore throat – two of the most common reasons for patients to visit their doctors.
26 Nov 2019
At the recent Takeda Malaysia Vocinti® (vonoprazan) launch, held in conjunction with the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2019 at Shangri-La Kuala Lumpur, Professor Akihito spoke about vonoprazan’s merits as an alternative to conventional proton pump inhibitors.
Dr Raghav Sundar, 09 Sep 2019

Overall survival (OS) is currently the primary criteria in assessing the efficacy of a cancer treatment. Dr Raghav Sundar, a consultant medical oncologist at the National University Hospital, Singapore, details the crucial role played by tumour response in evaluating treatment efficacy, with a focus on the multiple kinase inhibitor lenvatinib in the treatment of hepatocellular carcinoma (HCC).  

17 Jul 2019
All Helicobacters are urease-positive, able to convert aminoacids and urea into ammonia to neutralize stomach acid, andhighly mobile – characteristics that help them invade the mucosallayer to evade the body’s immune response. Helicobacter pylori(H. pylori) is linked to peptic ulcer disease, chronic gastritis,gastric mucosa-associated lymphoid tissue lymphoma, andearly gastric cancer. The infection rate of H. pylori is over 80% indeveloping countries and 20–50% in industrialized nations, withover 4.4 billion people testing positive for the bacteria in 2015.1,2
Dr Joslyn Ngu, 04 Dec 2017

Advancements in genomics has paved the way for better classifications of colorectal cancers (CRC) and the use of precision therapy.

Conference Reports
Roshini Claire Anthony, 19 Jun 2020

A once-daily maintenance dose of vonoprazan 10 mg or 20 mg may be a suitable substitute to lansoprazole in reducing the risk of erosive oesophagitis (EE) recurrence, according to a phase III noninferiority study presented at DDW 2020.

Elvira Manzano, 17 Jun 2020
Too much or too little sleep triggers constipation in a study of nearly 15,000 adults.
Roshini Claire Anthony, 16 Jun 2020

Regular use of aspirin may reduce the risk of gastrointestinal cancers, according to two studies presented at DDW 2020.

Audrey Abella, 16 Jun 2020
The guanylate cyclase-C receptor agonist plecanatide is effective and well-tolerated by older individuals (≥65 years) with chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C), results of a post hoc analysis presented at DDW 2020 has shown.
Roshini Claire Anthony, 15 Jun 2020

Patients with irritable bowel syndrome with diarrhoea (IBS-D) who have not responded to other medications may benefit from rifaximin, post hoc analyses of the TARGET 3* trial showed.

Audrey Abella, 12 Jun 2020
Maintenance therapy with a new subcutaneous (SC) formulation of the monoclonal antibody vedolizumab led to improvements in patient-reported outcomes (PROs) in patients with moderate-to-severe active Crohn’s disease (CD) compared with placebo, interim results of the phase III VISIBLE 2 study has shown.
Audrey Abella, 08 Jun 2020
Budesonide oral suspension (BOS), a liquid formulation of a topical corticosteroid, improved endoscopic outcomes in patients with eosinophilic oesophagitis (EoE), a phase III trial has shown.
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download